Thromb Haemost 2009; 101(02): 345-350
DOI: 10.1160/TH08-07-0484
Endothelium and Vascular Biology
Schattauer GmbH

Prolonged exposure to high insulin impairs the endothelial PI3-kinase/Akt/nitric oxide signalling

Rosalinda Madonna
1   Institute of Cardiology, and Center of Excellence on Aging, “G. d’Annunzio” University, Chieti, Italy
,
Raffaele De Caterina
1   Institute of Cardiology, and Center of Excellence on Aging, “G. d’Annunzio” University, Chieti, Italy
2   CNR Institute of Clinical Physiology, Pisa, Italy
› Author Affiliations
Financial support: This work has been supported through funding from the Center of Excellence on Aging (C.E.A.) Project, through a PRIN grant from the Italian Ministry of the University and Scientific Research, and through a grant from the Istituto Nazionale Ricerche Cardio -vascolari (I.N.R.C.), all to the Chair and Institute of Cardiology at “G. d’Annunzio” University, Chieti.
Further Information

Publication History

Received: 28 July 2008

Accepted after minor revision: 20 January 2008

Publication Date:
23 November 2017 (online)

Summary

Hyperinsulinemia predicts future cardiovascular events, but may also contribute to atherosclerosis. We therefore studied the consequences of prolonged insulin treatment of human umbilical vein endothelial cells (HUVEC) on the phosphatidylinositol-3‘-kinase(PI3K)/Akt/nitric oxide(NO)-dependent insulin signaling, together with the expression of the pro-atherogenic molecule vascular cell adhesion molecule (VCAM)-1. HUVEC were incubated with insulin (10–11 to 10–7 M) in short- (30 min) and long-term (24 h to 3 days) incubations. In short-term incubations, insulin did not affect constitutive Akt and eNOS at any concentration, but significantly increased their active phosphorylated forms, and NO production. In long-term incubations, however, such insulin effects on the phosphorylated forms, as well as NO production, were attenuated, promoting an effect of insulin also at concentrations otherwise ineffective. Such effects were accompanied by a boosting of insulin effect on VCAM-1 surface expression. In contrast, under similar conditions, insulin did not exert any significant effect on the surface expression of ICAM-1 and E-selectin. Therefore, prolonged exposure of HUVEC to high insulin levels induces a downregulation of the PI3K/Akt/eNOS axis. Such impairment of insulin signalling in states of prolonged hyperinsulinemia pontially contributes to detrimental effects on atherogenesis in insulin resistance states, such as the metabolic syndrome and type 2 diabetes.

 
  • References

  • 1 Kashyap SR, Defronzo RA. The insulin resistance syndrome: physiological considerations. Diab Vasc Dis Res 2007; 4: 13-19.
  • 2 Del Prato S, Leonetti F, Simonson DC. et al. Effect of sustained physiologic hyperinsulinaemia and hyper-glycaemia on insulin secretion and insulin sensitivity in man. Diabetologia 1994; 37: 1025-1035.
  • 3 Koopmans SJ, Ohman L, Haywood JR. et al. Seven days of euglycemic hyperinsulinemia induces insulin resistance for glucose metabolism but not hypertension, elevated catecholamine levels, or increased sodium retention in conscious normal rats. Diabetes 1997; 46: 1572-1578.
  • 4 Hirashima Y, Tsuruzoe K, Kodama S. et al. Insulin down-regulates insulin receptor substrate-2 expression through the phosphatidylinositol 3-kinase/Akt pathway. J Endocrinol 2003; 179: 253-266.
  • 5 Pirola L, Bonnafous S, Johnston AM. et al. Phosphoinositide 3-kinase-mediated reduction of insulin receptor substrate-1/2 protein expression via different mechanisms contributes to the insulin-induced desensitization of its signaling pathways in L6 muscle cells. J Biol Chem 2003; 278: 15641-15651.
  • 6 Bertacca A, Ciccarone A, Cecchetti P. et al. Continually high insulin levels impair Akt phosphorylation and glucose transport in human myoblasts. Metabolism 2005; 54: 1687-1693.
  • 7 Ueno M, Carvalheira JB, Tambascia RC. et al. Regulation of insulin signalling by hyperinsulinaemia: role of IRS-1/2 serine phosphorylation and the mTOR/p70 S6K pathway. Diabetologia 2005; 48: 506-518.
  • 8 Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 2006; 7: 85-96.
  • 9 Sun XJ, Rothenberg P, Kahn CR. et al. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 1991; 352: 73-77.
  • 10 Tanti JF, Gual P, Gremeaux T. et al. Alteration in insulin action: role of IRS-1 serine phosphorylation in the retroregulation of insulin signalling. Ann Endocrinol (Paris) 2004; 65: 43-48.
  • 11 Gual P, Le Marchand-Brustel Y, Tanti JF. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 2004; 87: 99-109.
  • 12 Zeng G, Quon MJ. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J Clin Invest 1996; 98: 894-898.
  • 13 Jersmann HP, Hii CS, Ferrante JV. et al. Bacterial lipopolysaccharide and tumor necrosis factor alpha synergistically increase expression of human endothelial adhesion molecules through activation of NF-kappaB and p38 mitogen-activated protein kinase signaling pathways. Infect Immun 2001; 69: 1273-1279.
  • 14 De Caterina R, Libby P, Peng HB. et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995; 96: 60-68.
  • 15 Araki E, Lipes MA, Patti ME. et al. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 1994; 372: 186-190.
  • 16 Bruning JC, Winnay J, Bonner-Weir S. et al. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 1997; 88: 561-572.
  • 17 Kido Y, Burks DJ, Withers D. et al. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. J Clin Invest 2000; 105: 199-205.
  • 18 Shirakami A, Toyonaga T, Tsuruzoe K. et al. Heterozygous knockout of the IRS-1 gene in mice enhances obesity-linked insulin resistance: a possible model for the development of type 2 diabetes. J Endocrinol 2002; 174: 309-319.
  • 19 Saad MJ, Araki E, Miralpeix M. et al. Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance. J Clin Invest 1992; 90: 1839-1849.
  • 20 Cybulsky MI, Iiyama K, Li H. et al. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 2001; 107: 1255-1262.
  • 21 Carluccio MA, Siculella L, Ancora MA. et al. Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals. Arterioscler Thromb Vasc Biol 2003; 23: 622-629.
  • 22 Saad MF, Knowler WC, Pettitt DJ. et al. Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes. Lancet 1989; 1: 1356-1359.
  • 23 Madonna R, Massaro M, De Caterina R. Insulin potentiates cytokine-induced VCAM-1 expression in human endothelial cells. Biochim Biophys Acta 2008; 1782: 511-516.
  • 24 Montagnani M, Golovchenko I, Kim I. et al. Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells. J Biol Chem 2002; 277: 1794-1799.
  • 25 Madonna R, Pandolfi A, Massaro M. et al. Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen-activated protein-kinase. Diabetologia 2004; 47: 532-536.
  • 26 Jiang ZY, Lin YW, Clemont A. et al. Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest 1999; 104: 447-457.
  • 27 Madonna R, Massaro M, Pandolfi A. et al. The prominent role of p38 mitogen-activated protein kinase in insulin-mediated enhancement of VCAM-1 expression in endothelial cells. Int J Immunopathol Pharmacol 2007; 20: 539-555.
  • 28 Heydrick SJ, Jullien D, Gautier N. et al. Defect in skeletal muscle phosphatidylinositol-3-kinase in obese insulin-resistant mice. J Clin Invest 1993; 91: 1358-1366.
  • 29 Le Roith D, Zick Y. Recent advances in our understanding of insulin action and insulin resistance. Diabetes Care 2001; 24: 588-597.